The following abstract from ASCO is simply giving the details of a clinical trial that is about to enroll patients with mantle cell lymphoma. If you have MCL you will certainly want to discuss the merits of participating in this trial with your doctor. Ibrutinib has been getting some amazing results in recent studies.
A phase III study of ibrutinib in combination with bendamustine and rituximab (BR) in elderly patients with newly diagnosed mantle cell lymphoma (MCL).
http://abstracts2.asco.org/AbstView_132_113203.html
No comments:
Post a Comment